Medication Harm Reduction

Medication Harm Reduction is a clinical strategy within oncology pharmacotherapy that systematically identifies and mitigates adverse drug effects through the rational discontinuation or modification of nonessential, inappropriate, or harmful medications to optimize patient outcomes.

275

Publications

11.4K

Citations

1.2K

Authors

589

Institutions

Publications per year

2017–2026

156

Authors

1.2K

  1. TP
    Timothy Piatkowski

    Griffith University, Australia

    4 publications · 156 citations

    5

    h-index

  2. JP
    Jonathan P. Caulkins

    Carnegie Mellon University, United States

    4 publications · 110 citations

    4

    h-index

  3. CG
    Coral Gartner

    The University of Queensland, Australia

    3 publications · 49 citations

    4

    h-index

  4. TC
    Traci C. Green

    Brown University, United States

    3 publications · 68 citations

    4

    h-index

  5. GJ
    Gregory J. Dore

    UNSW Sydney, Australia

    4 publications · 569 citations

    4

    h-index

1–5 of 1.2K

Venues

  1. International Journal of Drug Policy

    26 publications · 1K citations

    17

    h-index

  2. Harm Reduction Journal

    HRJ · 19 publications · 823 citations

    16

    h-index

  3. Addiction

    13 publications · 1.1K citations

    13

    h-index

  4. PubMed

    Repository · 9 publications · 360 citations

    9

    h-index

  5. Drugs Education Prevention and Policy

    7 publications · 237 citations

    7

    h-index

1–5